Erika J. Ernst

3.4k total citations
71 papers, 2.7k citations indexed

About

Erika J. Ernst is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Erika J. Ernst has authored 71 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 27 papers in Infectious Diseases and 20 papers in Pharmacology. Recurrent topics in Erika J. Ernst's work include Antifungal resistance and susceptibility (18 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Fungal Infections and Studies (12 papers). Erika J. Ernst is often cited by papers focused on Antifungal resistance and susceptibility (18 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Fungal Infections and Studies (12 papers). Erika J. Ernst collaborates with scholars based in United States, Germany and Austria. Erika J. Ernst's co-authors include Michael E. Klepser, Michael A. Pfaller, Michael E. Ernst, Russell E. Lewis, Chris Petzold, Daniel J. Diekema, S. A. Messer, Alvaro Viljoen, Betül Demırcı and Sandy van Vuuren and has published in prestigious journals such as Neurology, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Erika J. Ernst

70 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erika J. Ernst United States 28 1.3k 1.0k 603 356 349 71 2.7k
Michael E. Klepser United States 37 2.0k 1.5× 1.7k 1.7× 847 1.4× 555 1.6× 451 1.3× 135 4.4k
Daniel J. Sheehan United States 17 1.6k 1.3× 1.0k 1.0× 302 0.5× 177 0.5× 167 0.5× 35 2.6k
L. Dubreuil France 31 696 0.5× 558 0.6× 261 0.4× 392 1.1× 447 1.3× 128 2.7k
Elvira Garza‐González Mexico 31 1.0k 0.8× 739 0.7× 193 0.3× 338 0.9× 287 0.8× 201 3.5k
Fumiaki Ikeda Japan 26 1.1k 0.9× 881 0.9× 525 0.9× 196 0.6× 83 0.2× 77 2.3k
Roger L. White United States 22 546 0.4× 416 0.4× 620 1.0× 146 0.4× 245 0.7× 52 2.1k
Alexander J. Lepak United States 28 1.4k 1.1× 1.0k 1.0× 669 1.1× 140 0.4× 78 0.2× 80 2.0k
Patrick De Mol Belgium 27 545 0.4× 453 0.4× 172 0.3× 301 0.8× 361 1.0× 90 2.5k
John A. Bosso United States 30 794 0.6× 933 0.9× 1.3k 2.2× 157 0.4× 241 0.7× 120 3.7k
Per Sandven Norway 29 1.9k 1.5× 1.5k 1.5× 158 0.3× 156 0.4× 177 0.5× 67 2.8k

Countries citing papers authored by Erika J. Ernst

Since Specialization
Citations

This map shows the geographic impact of Erika J. Ernst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika J. Ernst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika J. Ernst more than expected).

Fields of papers citing papers by Erika J. Ernst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika J. Ernst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika J. Ernst. The network helps show where Erika J. Ernst may publish in the future.

Co-authorship network of co-authors of Erika J. Ernst

This figure shows the co-authorship network connecting the top 25 collaborators of Erika J. Ernst. A scholar is included among the top collaborators of Erika J. Ernst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika J. Ernst. Erika J. Ernst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yiqing, Zhen Zhou, Jonathan Broder, et al.. (2024). Antibiotic Use and Subsequent Cognitive Decline and Dementia Risk in Healthy Older Adults. Neurology. 104(1). e210129–e210129. 1 indexed citations
2.
Ernst, Erika J., et al.. (2023). Urinary Tract Infection Frequency and Prescription Prophylaxis in Females and Males with Recurrent Urinary Tract Infection. Pathogens. 12(2). 170–170. 1 indexed citations
3.
McCreary, Erin K, et al.. (2020). Clinical Outcomes and Economic Impact of Oritavancin for Gram-Positive Infections: A Single Academic Medical Center Health System Experience. Drugs - Real World Outcomes. 7(S1). 13–19. 19 indexed citations
4.
Hoff, Brian M, Dilek İnce, Erika J. Ernst, et al.. (2018). Implementation of a Mobile Clinical Decision Support Application to Augment Local Antimicrobial Stewardship. Journal of Pathology Informatics. 9(1). 10–10. 19 indexed citations
5.
Ernst, Erika J., et al.. (2017). Incidence of Serotonin Syndrome With Combined Use of Linezolid and Serotonin Reuptake Inhibitors Compared With Linezolid Monotherapy. Journal of Clinical Psychopharmacology. 37(5). 518–523. 20 indexed citations
6.
7.
Ernst, Erika J.. (2012). Exploring the Science of Complementary and Alternative Medicine: Third Strategic Plan, 2011–2015. Focus on Alternative and Complementary Therapies. 17(1). 22 indexed citations
8.
Bergus, George, Cynthia Weber, Michael E. Ernst, & Erika J. Ernst. (2008). Do antibiotics affect the quality of life of patients with upper respiratory tract illnesses?: it might depend on one’s luck. International Journal of Clinical Practice. 62(6). 855–859. 3 indexed citations
9.
Klevay, Michael, et al.. (2007). Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection. Diagnostic Microbiology and Infectious Disease. 60(3). 273–277. 56 indexed citations
10.
Zillich, Alan J., Jason M. Sutherland, Stephen J. Wilson, et al.. (2006). Antimicrobial Use Control Measures to Prevent and Control Antimicrobial Resistance in US Hospitals. Infection Control and Hospital Epidemiology. 27(10). 1088–1095. 41 indexed citations
11.
Ernst, Erika J. & P. David Rogers. (2005). Antifungal agents: methods and protocols.. Humana Press eBooks. 18 indexed citations
12.
Ernst, Erika J., Daniel J. Diekema, Bonnie J. BootsMiller, et al.. (2004). Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data?. Diagnostic Microbiology and Infectious Disease. 49(2). 141–145. 31 indexed citations
13.
Diekema, Daniel J., Jon Yankey, Erika J. Ernst, et al.. (2003). Antimicrobial Resistance Trends and Outbreak Frequency in United States Hospitals. Clinical Infectious Diseases. 38(1). 78–85. 203 indexed citations
14.
15.
Ernst, Erika J., Michael E. Klepser, Chris Petzold, & Gary V. Doern. (2002). Evaluation of Survival and Pharmacodynamic Relationships for Five Fluoroquinolones in a Neutropenic Murine Model of Pneumococcal Lung Infection. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(4). 463–470. 13 indexed citations
16.
Ernst, Erika J.. (2001). Investigational Antifungal Agents. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(8P2). 165S–174S. 46 indexed citations
17.
Ernst, Erika J., et al.. (2000). Novel triazole antifungal agents. Expert Opinion on Investigational Drugs. 9(3). 593–605. 104 indexed citations
18.
Ernst, Michael E. & Erika J. Ernst. (1999). Effectively Treating Common Infections in Residents of Long‐Term Care Facilities. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(9). 1026–1035. 1 indexed citations
19.
Klepser, Michael E., Erika J. Ernst, Michael E. Ernst, & Michael A. Pfaller. (1997). Growth medium effect on the antifungal activity of LY 303366. Diagnostic Microbiology and Infectious Disease. 29(4). 227–231. 24 indexed citations
20.
Ernst, Erika J.. (1997). Clinical Anatomy and Management of Low Back Pain. Focus on Alternative and Complementary Therapies. 2(2). 84–84. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael E. Klepser Breakdown of academic impact, for papers by Daniel J. Sheehan Breakdown of academic impact, for papers by L. Dubreuil Breakdown of academic impact, for papers by Elvira Garza‐González Breakdown of academic impact, for papers by Fumiaki Ikeda Breakdown of academic impact, for papers by Roger L. White Breakdown of academic impact, for papers by Alexander J. Lepak Breakdown of academic impact, for papers by Patrick De Mol Breakdown of academic impact, for papers by John A. Bosso Breakdown of academic impact, for papers by Per Sandven
Rankless by CCL
2026